СИМПТОМАТИЧЕСКАЯ ТЕРАПИИ РАССЕЯННОГО СКЛЕРОЗА: КОРРЕКЦИЯ ПСИХОЭМОЦИОНАЛЬНЫХ НАРУШЕНИЙ


Цитировать

Полный текст

Аннотация

Представлены современные данные, в том числе результаты собственных исследований, о патогенетических механизмах психоэмоциональных нарушений при рассеянном склерозе. Обобщены результаты доказательных исследований эффективности фармакотерапии и нефармакологических методов коррекции депрессии и хронической усталости.

Об авторах

Николай Николаевич Спирин

ГОУ ВПО «Ярославская государственная медицинская академия Росздрава»

Email: nnspirin@yandex.ru
ГОУ ВПО «Ярославская государственная медицинская академия Росздрава»

Дмитрий Сергеевич Касаткин

МУЗ «Городская поликлиника №5»

Email: mirsil@mail.ru
МУЗ «Городская поликлиника №5»

Список литературы

  1. Касаткин, Д.С. Возможные механизмы формирования синдрома усталости в клинике рассеянного склероза / Д.С. Касаткин, Н.Н. Спирин // Журн. неврол. и психиатр. им. С.С. Корсакова. Рассеянный склероз: приложение к журн. - 2006. - Вып. 3. - С. 87-92.
  2. Barak, Y. Moclobemide treatment in multiple sclerosis patients with comorbid depression: an open-label safety trial / Y. Barak, E. Ur, A. Achiron // J. Neuropsychiatry Clin. Neurosci. - 1999. - Vol.11. - P. 271-273.
  3. Beenakker, E.A. Cooling garment treatment in MS: clinical improvement and decrease in leukocyte NO production / E.A. Beenakker, T.I. Oparina, A. Hartgring et al. // Neurology. - 2001. - Vol.57. - P. 892-894.
  4. Chwastiak, L. Depressive symptoms and severity of illness in multiple sclerosis: epidemiologic study of a large community sample / L. Chwastiak, D.M. Ehde, L.E. Gibbons et al. // Am. J. Psychiatry. - 2002. - Vol.159. - P.1862-1868.
  5. Cohen, R.A. Amantadine treatment of fatigue associated with multiple sclerosis / R.A. Cohen, M. Fisher // Arch. Neurol. - 1989. - Vol.46. - P. 676-680.
  6. Crawford, J.D. Group psychotherapy: benefits in multiple sclerosis / J.D. Crawford, G.P. McIvor // Arch. Phys. Med. Rehabil. - 1985. - Vol.66. - P. 810-813.
  7. Di Fabio, R.P. Extended outpatient rehabilitation: its influence on symptom frequency, fatigue, and functional status for persons with progressive multiple sclerosis / R.P. Di Fabio, J. Soderberg, T. Choi et al. // Arch. Phys. Med. Rehabil. - 1998. - Vol.79. - P. 141-146.
  8. Du Boistesselin, R. Hydrotherapeutics and biophysiolo-gical de velopments. Roles of certain regulatory structures in asthenia: detection of Arcalion binding by histofluorescence // Gaz. Med. - 1988. - Vol. 95, Suppl.3. - P. 21-24.
  9. Ebers, G.C. Clinical features In: Multiple Sclerosis [Paty D.W., Ebers G.C. (eds)]. - Philadelphia: FA Davis, 1998. - P. 135-182.
  10. Feuerstein, С. Neurophysiological data concerning fatigue. Role of activator reticular formation // Entretiens de Bichat. - 1992. - Hors-serie. - P. 11-19.
  11. Finlayson, M. Pilot study of an energy conservation education program delivered by telephone conference call to people with multiple sclerosis // NeuroRehabilitation. - 2005. - Vol.20. - P. 267-277.
  12. Fisk, J.D. The Impact of Fatigue on Patients with Multiple Sclerosis / J.D. Fisk, A. Pontefract, P.G. Ritvo et al. // Can. J. Neurol. Sci. - 1994. - Vol.21. - P. 9-14.
  13. Flensner, G. The cooling-suit: case studies of its influence on fatigue among eight individuals with multiple sclerosis / G. Flensner, C. Lindencrona // J. Adv. Nurs. - 2002. - Vol.37. - P. 541-550.
  14. Freal, J.E. Symptomatic fatigue in multiple sclerosis / J.E. Freal, G.H. Kraft, J.K. Coryell // Arch. Phys. Med. Rehabil. - 1984. - Vol.65. - P.135-138.
  15. Gil, D. Antidepressants for depression in medical illness / D. Gil, S. Hatcher // Cochrane Database Syst. Rev. - 2000. - Vol.4. - CD001312.
  16. Heesen, C. Cognitive impairment correlates with hypothalamo-pituitary-adrenal axis dysregulation in multiple sclerosis / C. Heesen, S.M. Gold, A. Raji et al. // Psychoneuroendocrinology. - 2002. - Vol.27, №4. - P.505-517.
  17. IFNB Multiple Sclerosis Study Group Interferon beta-1b is effective in relapsing-remitting multiple sclerosis. Clinical results of a multicentre, randomized, double-blind, placebo-controlled trial // Neurology. - 1993. - Vol. 43. - P.655-661.
  18. Iriarte, J. Modalities of fatigue in multiple sclerosis: correlation with clinical and biological factors / J. Iriarte, M.L. Subira, P. Castro // Mult.Scler. - 2000. - Vol.6. - №2. - P.124-130.
  19. Jacobs, L.D. Intramuscular Interferon beta-1a for disease progression in relapsing multiple sclerosis / L.D. Jacobs, D.L. Cookfair, R.A. Rudick et al. // Ann. Neurol. - 1996. - Vol.39. - P. 285-294.
  20. Kappos, L. Treatment with interferon beta-1b delays conversion to clinically definite and McDonald MS in patients with clinically isolated syndromes / L. Kappos, C.H. Polman, M.S. Freedman et al. // Neurology. - 2006. - Vol.67, №7. - P.1242-1249.
  21. Kraft, G.H. Modafinil for fatigue in MS: a randomized placebo-controlled double-blind study / G.H. Kraft, J. Bowen // Neurology. - 2005. - Vol.65. - P.1995-1997.
  22. Krupp, L.B. Fatigue in multiple sclerosis / L.B. Krupp, L.A. Alvarez, N.G. LaRocca et al. // Arch. Neurol. - 1989. - Vol.46. - P. 841-842.
  23. Krupp, L.B. The fatigue severity scale: application to patients with multiple sclerosis and systemic lupus erythematosus / L.B. Krupp, N.G. LaRocca, J. Muir-Nash et al. // Arch. Neurol. - 1989. - Vol.46. - P. 1121-1123.
  24. Krupp, L.B. Fatigue therapy in multiple sclerosis: results of a double-blind, randomized, parallel trial of amantadine, pemoline, and placebo / L.B. Krupp, P.K. Coyle, C. Doscher et al. // Neurology. - 1995. - Vol.45. - P. 1956-1961.
  25. Mathiowetz, V.G. Efficacy of an energy conservation course for persons with multiple sclerosis / V.G. Mathiowetz, K.M. Matuska, M.E. Murphy // Arch. Phys. Med. Rehabil. - 2001. - Vol.82. - P. 449-456.
  26. Mathiowetz, V.G. Randomized controlled trial of an energy conservation course for persons with multple sclerosis / V.G. Mathiowetz, M.L. Finlayson, K.M. Matuska et al. // Multiple Sclerosis. - 2005. - Vol.11. - P. 592-601.
  27. Mendoza, R.J. Unit management of depression of patients with multiple sclerosis using cognitive remediation strategies: a preliminary study / R.J. Mendoza, D.J. Pittenger, C.S. Weinstein // Neurorehabil. Neural. Repair. - 2001. - Vol.15. - P. 9-14.
  28. Metz, L.M. The effect of immunomodulatory treatment on multiple sclerosis fatigue / L.M. Metz, S.B. Patten, C.J. Archibald et al. // J. Neurol. Neurosurg. Psychiatry. - 2004. - Vol.75, 7. - P. 1045-1047.
  29. Mohr, D.C. Comparative outcomes for individual cognitive-behaviour therapy, supportive-expressive group psycho-therapy, and sertraline for the treatment of depression in multiple sclerosis / D.C. Mohr, A.C. Boudewyn, D.E. Goodkin et al. // J. Consult. Clin. Psychol. - 2001. - Vol.69. - P. 942-949.
  30. Mohr, D.C. A preliminary report on a skills-based telephone-administered peer support programme for patients with multiple sclerosis / D.C. Mohr, H. Burke, V. Beckner et al. // Mult. Scler. - 2005. - Vol.11. - P. 222-226.
  31. Mostert, S. Effects of a short-term exercise training program on aerobic fitness, fatigue, health perception and activity level of subjects with multiple sclerosis / S. Mostert, J. Kesselring // Mult. Scler. - 2002. - Vol.8. - P. 161-168.
  32. Mostert, S. Effect of pulsed magnetic field therapy on the level of fatigue in patients with MS - a randomised controlled trial / S. Mostert, J. Kesselring // Mult. Scler. - 2005. - Vol.11. - P. 302-305.
  33. Oken, B.S. Randomzied controlled trial of yog and exercise in multiple sclerosis / B.S. Oken, S. Kishiyama, D. Zajdel et al. // Neurology. - 2004. - Vol.62. - P. 2058-2064.
  34. Patti, F. The impact of outpatient rehabilitation on quality of life in multiple sclerosis / F. Patti, M.R. Ciancio, E. Reggio et al. // J. Neurol. - 2002. - Vol. 249. - P. 1027-1033.
  35. Petajan, J.H. Impact of aerobic training on fitness and quality of life in multiple sclerosis / J.H. Petajan, E. Gappmaier, A.T. White et al. // Ann. Neurol. - 1996. - Vol.39. - P. 432-441.
  36. Polman, C.H. 4-Aminopyridine is superior to 3,4-diaminopyridine in the treatment of patients with multiple sclerosis / C.H. Polman, F.W. Bertelsmann, R. de Waal et al. // Arch. Neurol. - 1994. - Vol.51. - P. 1136-1139.
  37. PRISMS (Prevention of Relapses and Disability by Interferon beta-1a subcutaneously in Multiple Sclerosis) Study Group Randomised double-blind placebo-controlled study of Interferon beta-1a in relapsing-remitting multiple sclerosis // Lancet. - 1998. - Vol.352. - P.1498-1504.
  38. Rammohan, K.W. Modafinil for fatigue in MS: a rando-mized placebo-controlled double-blind study / K.W. Rammohan, D.J. Lynn // Neurology. - 2005. - Vol.65. - P. 1995-1997.
  39. Rammohan, K.W. Efficacy and safety of modafinil (Provigil) for the treatment of fatigue in multiple sclerosis: a two centre phase 2 study / K.W. Rammohan, J.H. Rosenberg, D.J. Lynn et al. // J. Neurol. Neurosurg. Psychiatry. - 2002. - Vol.72. - P.179-183.
  40. Rossini, P.M. Fatigue in progressive multiple sclerosis: results of a randomized, double-blind, placebo-controlled, crossover trial of oral 4-aminopyridine / P.M. Rossini, P. Pasqualetti, C. Pozzilli et al. // Mult. Scler. - 2001. - Vol.7. - P. 354-358.
  41. Schiffer, R.B. Antidepressant pharmacotherapy of depres-sion associated with multiple sclerosis / R.B. Schiffer, N.M. Wi-neman // Am. J. Psychiatry. - 1990. - Vol.147. - P. 1493-1497.
  42. Schwid, S.R. Fatigue in multiple sclerosis: Current understanding and future directions / S.R. Schwid, M. Covington, B.M. Segal et al. // J. Rehabil. Res. Dev. - 2002. - Vol.39. - №2. - P.211-224.
  43. Schwid, S.R. Quantitative assessment of sustained-release 4-aminopyridine for symptomatic treatment of multiple sclerosis / S.R. Schwid, M.D. Petrie, M.P. McDermott et al. // Neurology. - 1997. - Vol.48. - P. 817-821.
  44. Schwid, S.R. A randomized controlled study of the acute and chronic effects of cooling therapy for MS / S.R. Schwid, M.D. Petrie, R. Murray et al. // Neurology. - 2003. - Vol.60. - P. 1955-1960.
  45. Sheean, G.L. An open-labelled clinical and electrophysiological study of 3,4 diaminopyridine in the treatment of fatigue in multiple sclerosis / G.L. Sheean, N.M. Murray, J.C. Rothwell et al. // Brain. - 1998. - Vol.121. - P. 967-975.
  46. Surakka, J. Effects of aerobic and strength exercise on motor fatigue in men and women with multiple sclerosis: a randomized controlled trial / J. Surakka, A. Romberg, J. Ruutiainen et al. // Clin. Rehabil. - 2004. - Vol.18. - P. 737-748.
  47. Tomassini, V. Comparison of the effects of acetyl l-carnitine and amantadine for the treatment of fatigue in multiple sclerosis: results of a pilot, randomised, double-blind, crossover trial / V. Tomassini, C. Pozzilli, E. Onesti et al. // J. Neurol. Sci. - 2004. - Vol. 218. - P.103-108.
  48. Van Diemen, H.A. The effect of 4-aminopyridine on clinical signs in multiple sclerosis: a randomized, placebo-controlled, double-blind, cross-over study / H.A. Van Diemen, C.H. Polman, van T.M. Dongen et al. // Ann. Neurol. - 1992. - Vol.32. - P. 123-130.
  49. Weinshenker, B.G. A double-blind, randomized, crossover trial of pemoline in fatigue associated with multiple sclerosis / B.G. Weinshenker, M. Penman, B. Bass et al. // Neurology. - 1992. - Vol.42. - P. 1468-1471.
  50. White, A.T. Effect of precooling on physical performance in multiple sclerosis / A.T. White, T.E. Wilson, S.L. Davis et al. // Mult. Scler. - 2000. - Vol.6. - P.176-180.
  51. Wingerchuk, D.M. A randomized controlled crossover trial of aspirin for fatigue in multiple sclerosis / D.M. Win-gerchuk, E.E. Benarroch, P.C. O'Brien. // Neurology. - 2005. - Vol.64, №7. - P. 1267-1269.
  52. Zephir, H. Multiple sclerosis and depression: influence of interferon beta therapy / H. Zephir, J. De Seze, T. Stojkovic et al. // Mult. Scler. - 2003. - Vol. 9. - P. 284-288.
  53. Ziemssen, T. Effects of glatiramer acetate on fatigue and days of absence from work in first-time treated relapsing-remitting multiple sclerosis / T. Ziemssen, J. Hoffman, R. Apfel et al. // Health Qual. Life Outcomes. - 2008. - Vol.6. - P. 67.
  54. Ziemssen, T. Multiple sclerosis beyond EDSS: depression and fatigue // J. Neurol. Sci. - 2009. - Vol.277. - Suppl.1. - P. 37-41.
  55. Zifko, U.A. Modafinil in treatment of fatigue in multiple sclerosis. Results of an open-label study / U.A. Zifko, M. Rupp, S. Schwarz et al. // J. Neurol. - 2002. - Vol.249. - P. 983-987.

© Спирин Н.Н., Касаткин Д.С., 2010

Creative Commons License
Эта статья доступна по лицензии Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.

Данный сайт использует cookie-файлы

Продолжая использовать наш сайт, вы даете согласие на обработку файлов cookie, которые обеспечивают правильную работу сайта.

О куки-файлах